Rajasthan Antibiotics Ltd, a active public limited company, was established on 17 March 1986 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231DL1986PLC023616. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹13.88 Cr and a paid-up capital of ₹9.57 Cr.
Formerly known as Cepham Medical Leasing Ltd. It upholds a compliant status. Employing 314 professional, Its leadership includes Aashish Pruthii (Managing Director), Bindu Acharya (Director), Vijaysinh Vanvirsinh Chauhan (Director). Past directors included Aashish Pruthii, Satish Kumar Mehta, Sushma Pruthi. It holds ₹117.84 Cr open charges and ₹729.68 Cr settled loans. Its latest AGM occurred on 14 August 2025, with the balance sheet filed on 31 March 2025. It is based at M-134, 2Nd Floor, Connaught Circus, New Delhi, Delhi, 110001.
U24231DL1986PLC023616
023616
17 March 1986
₹13.88 Cr
₹9.57 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Rajasthan Antibiotics Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Aashish Pruthii | Managing Director | 01 Jan 2007 | Current |
| Bindu Acharya | Director | 03 Jan 2022 | Current |
| Vijaysinh Vanvirsinh Chauhan | Director | 19 May 2022 | Current |
| Arvind Kharabanda | Director | 19 May 2022 | Current |
| Rakesh Kumar Girdhar | Whole-Time Director | 01 Nov 2008 | Current |
| Rajesh Kumar Jha | Director | 29 Jan 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Apr 2010 | Past |
| Pramod Abcsdd | Director | 06 Jun 2011 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Director | 01 Dec 2008 | Past |
| Pramod Abcsdd | Director | 17 May 2022 | Past |
| Pramod Abcsdd | Director | 24 Aug 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rajasthan Antibiotics Ltd, for the financial year ended 2025, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2024, Rajasthan Antibiotics had a promoter holding of 68.18% and a public holding of 31.82%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,178,373,200.00
₹7,296,777,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Dec 2024 | Yes Bank Limited | ₹19.50 Cr | Open |
| 02 Dec 2024 | Indian Bank | ₹7.50 Cr | Open |
| 19 Mar 2024 | Indian Bank | ₹3.40 Cr | Open |
| 19 Jan 2024 | Hdfc Bank Limited | ₹0.52 M | Open |
| 05 Jun 2023 | Indian Bank | ₹4.00 Cr | Open |
Explore comprehensive loan charge details -
Rajasthan Antibiotics has a workforce of 314 employees as of Sep 23, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Rajasthan Antibiotics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rajasthan Antibiotics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Rajasthan Antibiotics Ltd last Annual general meeting of members was held on 14 Aug 2025 as per latest MCA records. was completed.
Rajasthan Antibiotics Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.
Progress on A charge with Yes Bank Limited amounted to Rs. 19.50 Cr with Charge ID 101020708 was registered on 16 Dec 2024. was documented.
The activity A charge with Indian Bank amounted to Rs. 7.50 Cr with Charge ID 101051050 was registered on 02 Dec 2024. was completed.
A charge with Indian Bank amounted to Rs. 3.40 Cr with Charge ID 100899398 was registered on 19 Mar 2024. was recorded as a recent event.
The activity A charge registered on 15 Feb 2022 via Charge ID 100557345 with State Bank Of India was fully satisfied on 26 Feb 2024. was completed.
The CIN of Rajasthan Antibiotics Ltd is U24231DL1986PLC023616.
Rajasthan Antibiotics Ltd is headquartered at M-134, 2Nd Floor, Connaught Circus, New Delhi, Delhi, 110001.
Rajasthan Antibiotics Ltd was incorporated on 17 March 1986.
The current directors of Rajasthan Antibiotics Ltd are
The primary industry of Rajasthan Antibiotics Ltd is Manufacturing.
Rajasthan Antibiotics Ltd is unlisted.
The authorized capital of Rajasthan Antibiotics Ltd is ₹13.88 Cr, and the paid-up capital is ₹9.57 Cr.
The compliance status of Rajasthan Antibiotics Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX